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This study was conducted to evaluate the safety potential of the leaf extract of Ageratum conyzoides 
Linnaeus in Sprague Dawley (SD) rats using biochemical, haematological and histological indices of 
toxicity. Four groups of seven male SD rats per group were used for the study. To group A was 
administered 0.25% CMC-Na/ kg body weight and was used as the control group, while groups B, C and 
D were respectively administered with 500, 1000 and 1500 mg/kg body weight of the ethanolic leaf 
extract of A. conyzoides by gastric intubation for 14 days. Animals were subsequently anaesthetized, 
blood samples were collected for biochemical and haematological assays; organs were isolated and 
weighed, while the liver, kidney and spleen were processed for histopathological studies. Aspartate 
amino transferase, lactate dehydrogenase, creatine kinase and alkaline phosphatase were significantly 
(p < 0.05) reduced in the groups treated with 1000 and 1500 mg/kg body weight of the extract. 
Furthermore, there was a significant (p < 0.05) elevation in white blood cell count, mean platelet volume 
and % platelet distribution width. Histopathological studies indicated various degrees of hepatocellular 
necrosis in all the treated groups accompanied by significant increases in the weight of liver and 
spleen. The results showed that the ethanolic leaf extract of A. conyzoides significantly alters the 
biomarkers of cardiac and skeletal muscle disorders, and higher doses could induce liver cell injury. 
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INTRODUCTION 
 
Plants have been used in Africa for many centuries and 
today, almost all parts of the world use medicinal plants 
for the treatment of different types of diseases (Adebayo 
et al., 2006). Ageratum conyzoides Linnaeus belongs to 
the   family   and   tribe   of   Asteraceae  and  Eupatoriae  
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respectively. The plant is native to Central America, 
Caribbean, Florida (USA), Southeast Asia, South China, 
India, West Africa (including Nigeria), Australia and South 
America (Kong, 2006; Okunade, 2002). It is traditionally 
called “ufu opioko” and “otogo” by the Igedes in Benue 
State, Nigeria (Igoli et al., 2005). In Southwestern 
Nigeria, it is known as “Imí esu” (Oladejo et al., 2003). A. 
conyzoides has been used in folklore for the treatment of 
fever, pneumonia, cold, rheumatism, spasm, headache 
and curing wounds (Shirwaikar et al., 2003; Ming, 1999). 
Its gastroprotective (Shirwaikar et al., 2003), antibacterial,   
  
 
 
anti-inflammatory, antianalgesic and antipyretic 
(Okunade, 2002) and anticonvulsant (Whittle and Turner, 
1981) properties have been reported. A. conyzoides has 
been reported to possess activities against protozoan 
parasites like plasmodium (Madureira et al., 2002) and 
trypanosomes (Freiburghaus et al., 1996). Its 
antischistosomal (El Sheikh et al., 1990), anticancer, 
antiradical (Adebayo et al., 2010) and anticoccidal 
activities (Nweze and Obiwulu, 2009) have been 
reported. A. conyzoides has been widely reported to 
contain many bioactive compounds which are 
responsible for its diverse biological activities. Among 
them are flavonoids, tannins, saponins, triterpenoids, 
sesquiterpenes, chromenes, chromones, benzofurans, 
etc (Moreira et al., 2004, 2007; Okunade, 2002). 
Precocenes I and II are the principal components of the 
plant. Previous studies reported on the plant 
recommended for further work on the histological 
assessment of the plant with regards to its hepatotoxicity 
risk (Igboasoiyi et al., 2007; Moura et al., 2005). Thus, 
the insufficient information on the toxicity potential of A. 
conyzoides led to the present investigation. The study 
therefore is aimed at investigating the biochemical, 
haematological and histopathological effects of ethanolic 
leaf extract of A. conyzoides in Sprague Dawley (SD) 
rats. 
 
 
MATERIALS AND METHODS 
 
Plant material  
 
The leaves of A. conyzoides L. were collected between November, 
2007 and January, 2008 from Covenant University, Ota environs. A 
voucher specimen (PCGH 436) was deposited at the Department of 
Pharmacognosy, University of Lagos, Nigeria. 
 
 
Extraction of the plant 
 
The leaves of A. conyzoides were collected and air dried in the 
laboratory for two weeks after which they were blended into fine 
powder. Four hundred and thirty-five grams (435 g) of the powder 
were extracted with 95% ethanol for 18 h at 85°C and concentrated 
in a rotary evaporator (Buchi 461, Switzerland) at 50°C to afford  78 
g (17.9% yield) of  the crude extract (Adebayo et al., 2006). 
 
 
Experimental animals 
 
Twenty-eight male SD rats, specific pathogen free, aged 7 to 9 
weeks and weighing 220 - 265 g were purchased from Vital River 
Laboratories, Beijing, China and transported by air to the Animal 
House of the Institute of Toxicology, Kunming Medical University, 
Kunming, China. They were kept under standard environmental 
conditions (25 ± 21°C; 12/12 h light/dark cycle). Four animals were 
housed in each cage and fed with standard diet (obtained from 
Yunnan Key Laboratory of Animal Nutrition and Feed Stuff, Yunnan 
Agriculture University, China) and water ad libitum. The animals 
were allowed to acclimatize for two weeks before beginning the 
experiment. For experimentation, the animals were fasted overnight 
and  7  animals  were  included  in  each   group.   All   experimental 
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protocols were in compliance with the Institute of Toxicology, 
Kunming Medical University Ethics Committee on Research in 
Animals as well as other internationally accepted principles for 
laboratory animal use and care. 
 
 
Experimental design 
 
The experimental design was the modified versions of that reported 
by (Igboasoiyi et al., 2007; Moura et al., 2005). Four groups A, B, C 
and D were used for the sub-chronic experiment. Groups B, C and 
D were respectively administered 500, 1000 and 1500 mg/kg body 
weight of ethanolic leave extract of A. conyzoides (dissolved in 
0.25% CMC-Na) for 14 d. Group A which served as the control 
group was administered 0.25% CMC-Na per kg body weight. After 
this treatment period, animals were injected intravenously with 0.2 
ml/kg body weight of phenobarbital (sedative). They were 
subsequently dissected from the abdominal region; blood was 
collected from the pulmonary vein using the vacutainer system into 
EDTA anti-coagulated and non anti-coagulated tubes. The organs 
(liver, kidney, heart, spleen, brain, lungs, thymus, testes, epidydimis 
and adrenal gland) were also obtained for histological examination. 
The non-coagulated blood was allowed to clot at room temperature; 
the resultant clear part was centrifuged at 1500 x g for 10 min to 
obtain the serum; biochemical analyses were run immediately using 
the automated multi-item analyzer (TMS-1024, Tokyo Boeki 
Medical System Ltd., Japan). Similarly, the anticoagulated blood 
was immediately used for haematological assays using the 
automated haematology analyzer (ADVIA 60-OT, Bayer 
Corporation, Tarrytown, New York, USA).  
 
 
Biochemical and haematological assays 
 
Commercial test kits obtained from Biosino Bio-Technology and 
Science Inc. Beijing, China were used for all biochemical 
parameters measured. Standard methods were used to estimate 
glucose (Trinder, 1969), aspartate aminotransferase (AST) 
(Bergmeyer et al., 1986a),  alanine aminotransferase (ALT) 
(Bergmeyer et al., 1985b), alkaline phosphatase (ALP) (Tietz et al., 
1983), lactate dehydrogenase (LDH), creatine kinase (CK) 
(Chemnitz et al., 1979), total protein (Weichselbaum, 1946), albumin 
(Doumas et al., 1971), total bilirubin (Doumas et al., 1973), urea 
(Krieg et al., 1986), creatinine (Larsen et al., 1971), triglycerides, 
cholesterol (Zoppi and Fellini, 1976) and HDL-cholesterol 
(European Atherosclerosis Society, 1992). These parameters were 
determined using the automated biochemical muti-item analyzer 
(TMS-1024; Tokyo Boeki Medical System Ltd., Japan). The whole 
blood was used to assay white blood cell count (WBC), red blood 
cell count (RBC), haemoglobin (HGB), haematocrit (HCT), mean 
cell volume (MCV), mean corpuscular hemoglobin (MCH), mean 
corpuscular hemoglobin concentration (MCHC), red cell distribution 
width (RDW), platelet count (PLT), mean platelet volume (MPV), 
percentage lymphocyte (% LYM), percentage monocyte (% MON), 
percentage granulocyte (% GRA), platelet distribution width (PDW) 
and plateletcrit (PCT). These parameters were determined by 
automated haematology system analyzer (ADVIA 60 Open Tube; 
Bayer Corporation, Tarrytown, New York, USA).  
 
 
Histopathological studies 
 
The method as described by Aliyu et al. (2007) with slight 
modification was adopted. After blood collection, the liver, kidney 
and spleen were carefully dissected from the abdominal region. 
They were fixed in normal saline for 72 h and sliced into a thickness 
of 2.1 mm. The tissues were dehydrated with alcohol of graded 
concentrations. They  were  further  treated  with  paraffin  wax  and  
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Figure 1. Weights of Sprague Dawley rats treated with ethanolic leaf extract of A.conyzoides. Values are represented as 
mean ± SD of 7 replicates. Values on the same day with different letters differ significantly (p < 0.05).  
 
 
 
cast into blocks; sections of the tissues were then cut on a 
microtome to 5 µm. These were later attached to a slide and 
allowed to dry. The sample slides were subsequently stained in 
haematoxylin-eosin and examined under a light microscope; 
photomicrographs of the samples were recorded. 
 
 
Statistical analyses 
 
The differences among experimental and control groups were 
determined using SPSS for Window XP software programme 
(version 13.0). Group comparisons were done using the analysis of 
variance (ANOVA) test. Significant difference between control and 
experimental groups were assessed by least significant difference 
(LSD). All data were expressed as mean ± deviations (SD); p 
values less than 0.05 were considered to be significant. 
 
 
RESULTS 
 
Animal weights and weight of organs  
 
There was a considerable (p < 0.05) weight loss on the 
fourth day in rats treated with extract of 1500 mg/kg body 
weight of A. conyzoides, this was later followed with an 
insignificant (p > 0.05) weight gain during the remaining 
treatment duration (Figure 1). 
There was significant increase in the weight of liver of 
rats in groups C (p < 0.01) and D (p < 0.05) treated with 
the leaf extract of A. conyzoides (Table 1). Similarly, a 
significantly (p < 0.05) higher spleen was observed in 
group C of rats treated with the extract when compared 
with the control group. No significant (p > 0.05) difference 
was observed in lungs, heart, thymus, adrenal cortex, 
brain, epididymis, kidney and testes for the groups 
treated   with   the   ethanolic   extract  of  A . conyzoides. 
Biochemical and haematological assays 
 
Aspartate aminotransferase was significantly reduced in 
groups C (p < 0.01) and D (p < 0.05). There was no 
significant (p > 0.05) difference in alanine 
aminotransferase. Alkaline phosphatase was markedly 
decreased in all the treated groups but group C was 
significantly different (p < 0.05) from the control group 
(Table 2). Lactate dehydrogenase was significantly 
reduced (p < 0.05) in groups C and D when compared 
with the control group (Table 3). Similarly, creatine kinase 
was significantly decreased in groups C and D (p < 0.05) 
when compared with the control group. White blood cell 
was significantly higher (p < 0.05) in group D than the 
control group.  
There was a dose dependent increase in MPV 
concentration which was statistically significant (p < 0.05) 
compared with the control group. Similarly, the % PDW 
showed a dose-dependent elevation in all the treated 
groups and significantly different (p < 0.05) from the 
control group (Table 4).  
 
 
Histopathological studies 
 
All groups treated with the ethanolic extract of A. 
conyzoides showed various degrees of hepatocellular 
necrosis on the liver sectioning when compared with the 
control group (Figure 2). Group B showed four areas of 
spotty hepatocellular necrosis (Figure 3). 
Similarly, Group C had seven areas of spotty 
hepatocellular necrosis (Figure 4). Group D which was 
given the largest dose of 1500 mg/kg body weight of the 
extract had nine areas of spotty hepatocellular necrosis 
respectively (Figure 5). No significant damage was 
observed in rats kidney and  spleen  tissues  treated  with 
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Table 1. Effects of ethanolic leaf extract of Ageratum conyzoides on the weight of organs in SD rats. 
 
Organs (g) Group A Group B Group C Group D (Control) (500 mg/kg bw) (1000 mg/kg bw) (1500 mg/kg bw) 
Thymus (x 10-2) 30.98 ± 3.13 
a 
[11.11 ± 0.64] a 
39.33  ±  2.96 a 
[13.48  ±  0.86] a 
40.75  ±  5.89 a 
[13.70  ±  1.85] a 
36.14  ±  4.83 a 
[13.08  ±  1.60] a 
     
Adrenal gland  
(x 10-2 ) 
5.45 ± 0.96 a 
[1.98 ±0.32] a 
5.19  ±  0.34 a 
[1.78  ±  0.10] a 
5.60  ±  0.69 a 
[1.90  ±  0.22] a 
5.11  ±  0.40 a 
[1.85  ±  0.12] a 
     
Heart  0.96 ± 0.05 
a
 
[0.35 ± 0.01] a 
0.95  ±  0.03 a 
[0.33  ±  0.01] a 
0.99  ±  0.04 a 
[0.34  ±  0.01] a 
0.94  ±  0.04 a 
[0.34  ±  0.01] a 
     
Liver  7.81  ±  0.61 
a
 
[2.81  ±  0.09] a 
8.84  ±  0.32 a 
[3.04  ±  0.06] a 
10.66  ±  0.65 c 
[3.61  ±  0.20] c 
9.54  ±  0.49 b 
[3.46  ±  0.14] c 
     
Spleen  0.47  ±  0.03 
a
 
[0.17  ±  0.01] a 
0.56  ±  0.03 a 
[0.19  ±  0.01] a 
0.69  ±  0.06 b 
[0.23  ±  0.02] a 
0.62  ±  0.09 a 
[0.23  ±  0.04] a 
     
Lungs  1.14  ±  0.08 
a
 
[0.41  ±  0.02] a 
1.24  ±  0.05 a 
[0.43  ±  0.01] a 
1.29  ±  0.06 a 
[0.44  ±  0.01] a 
1.28  ±  0.07 a 
[0.47  ±  0.03] b 
     
Kidney  2.03  ±  0.12 
a
 
[0.74  ±  0.02] a 
2.03  ±  0.05 a 
[0.70  ±  0.01] a 
2.17  ±  0.05 a 
[0.73  ±  0.01] a 
2.02  ±  0.09 a 
[0.73  ±  0.02] a 
     
Brain  1.77  ±  0.05 
a
 
[0.65  ±  0.03] a 
1.81  ±  0.04 a 
[0.62  ±  0.01] a 
1.81 ±  0.03 a 
[0.61  ±  0.01] a 
1.82  ±  0.05 a 
[0.66  ±  0.02] a 
     
Testes  2.64  ±  0.11 
a
 
[0.97  ±  0.04] a 
2.73  ±  0.08 a 
[0.94  ±  0.04] a 
2.93  ±  0.10 a 
[0.99  ±  0.03] a 
2.88  ±  0.12 a 
[1.04  ±  0.03] a 
     
Epidydimis  0.89  ±  0.04 
a
 
[0.32  ±  0.01] a 
0.84  ±  0.04 a 
[0.29  ±  0.02] a 
0.90  ±  0.02 a 
[0.31  ±  0.01] a 
0.87  ±  0.06 a 
[0.31  ±  0.02] a 
 
Values are represented as mean ± SD of 7 replicates; values in parenthesis are % weight of organ with respect to the body weight of 
rats; Values on the same row followed by different superscript letters differ significantly (a p > 0.05, b p < 0.05, c p < 0.01 vs control). 
 
 
 
Table 2. Levels of biochemical markers of liver injury in Sprague Dawley rats on ethanolic leaf extract of A. conyzoides. 
 
Parameter Group A Group B Group C Group D (Control) (500 mg/kg bw) (1000 mg/kg bw) (1500 mg/kg bw) 
ALT (U/L) 48.60 ± 3.03 a 52.92 ± 3.17 a 49.40  ±  1.59 a 49.85 ± 4.62 a 
AST (U/L) 109.66 ± 4.83 a 108.15 ± 4.49 a 89.49  ±  6.08 c 92.94  ± 3.95 b 
ALP (U/L) 280.26 ± 12.20 a 245.66 ± 12.55 a 210.80  ±  17.06 b 255.75 ± 12.53 a 
Total bilirubin (µmol/L) 3.06  ± 0.26 a 3.02  ± 0.43 a 2.80 ± 0.58 a 3.49  ±  0.25 a 
Albumin (g/L) 36.81 ± 0.82 a 36.91 ± 0.34 a 36.74 ± 0.57 a 36.63  ±  0.63 a 
Total protein (g/L) 58.51 ± 0.72 a 56.84 ± 0.78 a 57.71 ± 0.99 a 57.16 ± 1.18 a 
Albumin/Globulin 1.72 ± 0.10 a 1.86 ±  0.05 a 1.76 ± 0.05 a 1.82 ± 0.10 a 
 
Values represent mean ± SD of 7 replicates. Values on the same row followed by different superscript letters differ significantly (a p > 0.005, b 
p < 0.05, c p < 0.01 vs control). 
 
 
 
extracts of A. conyzoides.  
 
 
DISCUSSION 
 
The safety of drugs and plant products for human use  can  
be determined using toxicological evaluation which is 
usually carried out in various experimental animals to 
predict toxicity and to provide guidelines for selecting a 
safe dose in humans. Analysis of blood parameters is 
relevant in risk evaluation as changes in the haematolo-
gical   system  have  higher  predictive  value  for  studies  
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Table 3. Some biochemical markers in sprague dawley rats on ethanolic leaf extract of A. conyzoides.  
  
    Parameter 
Group A Group B Group C Group D 
(Control) (500 mg/kg bw) (1000 mg/kg bw) (1500 mg/kg bw) 
     LDH (U/gprot) 1010.47 ± 106.60 a 1105.59± 144.89 a 710.39±  130.48 b 630.85 ± 41.35b 
Creatine kinase (U/L) 588.167± 24.94 a 589.85 ± 49.29 a 443.93 ± 96.38 b 407.16± 41.85b 
 Urea  (mmol/L) 6.46 ± 0.18 a 6.89 ± 0.40 a 7.53 ± 0.34 a 7.14 ± 0.41 a 
Creatinine(µmol/L) 24.77 ± 0.94 a 25.99 ± 0.72a 26.18 ± 1.66a 26.12 ± 0.99 a 
Total Cholesterol  (mmol/L) 1.45 ± 0.12 a 1.45 ±0.09 a 1.41 ± 0.10 a 1.48 ± 0.07 a 
HDL-Cholesterol (mmol/L) 1.05 ± 0.04 a 1.06 ± 0.08 a 1.01 ± 0.19 a 1.13 ± 0.08 a 
Triglyceride(mmol/L) 0.38 ± 0.02 a 0.34 ± 0.05 a 0.30 ± 0.01a 0.27 ± 0.05 a 
Glucose (mmol/L) 6.01 ± 0.34 a 5.57 ± 0.51 a 6.64 ± 0.42 a 5.49 ± 0.33 a 
 
Values represent mean ± SD of 7 replicates. Values on the same row followed by different superscript letters differ significantly (a p > 0.05, b p < 
0.05 vs control). 
 
 
 
Table 4. Haematological parameters in Sprague Dawley rats on ethanolic leaf extract of A. conyzoides. 
  
   Parameter Group A Group B Group C Group D (Control) (500 mg/kg bw) (1000 mg/kg bw) (1500 mg/kg bw) 
WBC (x 1012/L) 4.73 ± 0.55 a 6.00 ± 0.47 a 5.73 ± 0.98  a 6.97 ± 0.76 b 
RBC (x 1012/L) 6.65 ± 0.16 a 6.48 ± 0.09 a 6.49 ± 0.12 a 6.33 ± 0.13 a 
HGB (g/L) 140.00 ± 2.25 a 140.86 ± 2.61 a 140.00 ± 1.86 a 138.00 ± 3.32 a 
HCT (L/L) 0.34 ± 0.01 a 0.33 ± 0.01 a 0.34 ± 0.0 a 0.32 ± 0.02 a 
PLT (x 109/L) 989.00 ± 39.34 a 941.71 ± 47.54 a 953.00 ± 29.83 a 964.29 ± 38.83 a 
PCT (x 10-2L/L) 0.61 ± 0.03 a 0.57 ± 0.02 a 0.59 ± 0.02 a 0.60 ± 0.03 a 
MCV (fL) 50.33 ± 0.49 a 51.57 ± 0.72 a 50.83 ± 0.54 a 52.14 ± 0.96 a 
MCH (pg) 21.10 ± 0.30 a 21.67 ± 0.25 a 21.28 ± 0.30 a 21.81 ± 0.39 a 
MCHC (g/L) 418.83 ± 3.66 a 419.43 ± 2.11 a 417.33 ± 1.67 a 418 ± 2.17 a 
RDW (%) 12.93 ± 0.30 a 13.63 ± 0.17 a 13.50 ± 0.16 a 13.59 ± 0.26 a 
MPV (fL) 5.89 ± 0.07 a 6.06 ± 0.10 a 6.17 ± 0.07 b 6.23 ± 0.12 b 
PDW (%) 7.43 ± 0.08 a 7.93 ± 0.11 b 7.98 ± 0.08 b 8.13 ± 0.19 b 
Lymphocyte (%) 87.12 ± 1.74 a 80.70 ± 2.74 a 87.93 ± 2.04 a 78.41 ± 4.44 a 
Monocyte (%) 11.08 ± 1.32 a 16.99 ± 2.31 a 10.68 ± 1.71 a 17.16 ± 2.62 a 
Granulocyte (%) 1.80 ± 0.58 a 2.31 ± 0.46 a 1.38 ± 0.35 a 4.43 ± 1.91 a 
 
Values are represented as mean ± SD of 7 replicates. Values on the same row followed by different superscript letters differ 
significantly (a p > 0.05, b p < 0.05 vs control). White blood cell count (WBC), red blood cell count (RBC), haemoglobin (HGB), 
haematocrit (HCT), mean cell volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration 
(MCHC), red cell distribution width (RDW), platelet count (PLT), mean platelet volume (MPV), percentage lymphocyte, (% LYM), 
percentage monocyte (% MON), percentage granulocyte (% GRA), platelet distribution width (PDW) and plateletcrit (PCT). 
 
 
 
(Olson et al., 2000). From the observed values of WBC, it 
is clear that an increase in the number of WBC is a 
normal reaction of rats to foreign substances, which alter 
their normal physiological processes. The leucocytosis 
observed in the present study indicates a stimulation of 
the immune system which protects the rats against 
infection that might have been caused by chemical and 
secondary infections. Leucocytosis, which may be 
directly proportional to the severity of the causative stress 
condition, may be attributed to an increase in leukocyte 
mobilization (Celik and Suzek, 2008). The elevated level, 
human toxicity when the data are translated from animal 
of MPV and PDW in the extract may be due  to  high  rate 
of erythropoiesis occurring in the bone marrow of the rats 
(Rhiouani et al., 2008). The rise in ALT in the treated 
groups is an indication of hepatocellular injury. 
 ALT is a cytoplasmic enzyme found in very high 
concentration in the liver (Aliyu et al., 2007), and an 
increase of this specific enzyme indicates hepatocellular 
damage, while AST is less specific than ALT as an 
indicator of liver function. The toxicity exerted by 
ethanolic leaf extract of A. conyzoides was confirmed 
from histological sectioning which indicated various 
degrees of spotty hepatocellular necrosis in all the 
treated groups. The observed damage may be due to the 
fact that the liver being the first target of acute toxicity and  
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Figure 2. Photomicrograph of the section of liver architecture of Sprague Dawley rats showing normal 
features of control group A.  
 
 
 
 
 
Figure 3. Photomicrograph of group B administered with 500 mg/kg body weight of the extract of 
Ageratum conyzoides showing hepatocellular necrosis.  (HE stain, x400). 
 
 
 
the first organ exposed to everything that is absorbed in 
the small intestine, may metabolize foreign substances to 
highly reactive metabolites which may be hepatotoxic. In 
addition, because of the short duration of treatment, the 
alterations might be incipient and reversible, and not 
pronounced enough to change significantly serum ALT 
levels (Grance et al., 2008).  
ALP, a marker of obstructive jaundice and intrahepatic 
cholestasis (Davern and Scharschmidt, 2002) was 
significantly reduced; this further supported that the 
observed liver damage was not connected to biliary 
obstruction of the liver. The result obtained was partly in  
agreement with the work of Moura et al., (2005) involving 
rats   treated    with    the     hydroalcoholic     extract     of   
A. conyzoides leaves.ALT activity was high but not 
significant in one of the treated groups; they however, 
suggested that histological study be assessed in order to 
establish the hepatotoxicity potential of the plant. AST, 
LDH and CK are markers of skeletal and myocardial 
muscles (Laterza et al., 2008; Rasekh et al., 2008; 
Rosalki et al., 2004). When myocardial cells, containing 
LDH and CK are damaged or destroyed due to deficient 
oxygen supply or glucose, the cell membrane becomes 
permeable or may rapture, which results in the leakage of 
enzymes (Prince et al., 2008). The reduced significant 
activity of these markers suggests that the ethanolic leaf 
extract of A. conyzoides offered some protections against 
diseases related to the muscles. The significant reduction  
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Figure 4. Photomicrograph of group C administered with 1000 mg/kg body weight of extract of A. conyzoides indicating 
hepatocellular necrotic damage (HE stain, x400). 
 
 
 
 
  
Figure 5. Photomicrograph of group D administered with 1500 mg/kg body weight of A. conyzoides showing different 
locations of spotty hepatocellular necrosis (HE stain, x400). 
 
 
 
of AST level has further eliminated any leakage of the 
enzyme in the liver due to hepatic injury (since AST is a 
major marker of liver injury). Serum CK and LDH 
activities were significantly decreased in the treated rats. 
Urea and creatinine are considered as a suitable  
prognostic  indicator   of   renal   dysfunction   and  kidney 
failure for any toxic compounds (Gnanamani et al. 2008; 
Ashour et al., 2006). In the present study, no significant 
variations in the levels of urea and creatinine was 
observed; however, a slight insignificant increase in the 
level of urea and creatinine was noticed, thus suggesting 
the  non-toxicity  of  the  extract  to  the  kidney  within the 
  
 
 
treatment durations. The result from histological sec-
tioning was in agreement as there was no apparent 
damage to the kidney was observed in all the treated 
groups when compared with the control group, this 
therefore confirmed that the plant extract was non toxic to 
the kidney within the treatment durations. Previous 
biochemical studies have also confirmed the non-toxicity 
of the plant extract of A. conyzoides to the kidney 
(Igboasoiyi et al., 2007; Moura et al., 2005).  
 
 
Conclusion 
 
In conclusion, within the treatment dose and test 
duration, the ethanolic leaf extract of A. conyzoides 
showed significant reductions on markers of cardiac and 
skeletal muscles which could be recommended for the 
management of cardiac and skeletal diseases. But 
caution need to be taken on the appropriate dosage as 
higher concentration could induce hepatocellular 
necrosis. Further work is needed to ascertain the 
mechanism of action of the extract on the muscles. 
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